Published in Neuroscience on March 07, 2008
Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem (2009) 1.85
Transient elevation of adult hippocampal neurogenesis after dopamine depletion. Exp Neurol (2010) 0.96
Physical exercise-induced adult neurogenesis: a good strategy to prevent cognitive decline in neurodegenerative diseases? Biomed Res Int (2014) 0.87
Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF. Nat Commun (2014) 0.86
Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse. Brain Res (2011) 0.84
Allopregnanolone and neurogenesis in the nigrostriatal tract. Front Cell Neurosci (2014) 0.83
Environmental and behavioral modulation of the number of substantia nigra dopamine neurons in adult mice. Brain Behav (2013) 0.83
Enhanced adult neurogenesis increases brain stiffness: in vivo magnetic resonance elastography in a mouse model of dopamine depletion. PLoS One (2014) 0.82
Nestin-positive/SOX2-negative cells mediate adult neurogenesis of nigral dopaminergic neurons in mice. Neurosci Lett (2016) 0.80
Mutant α-synuclein and aging reduce neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Aging Cell (2010) 0.80
Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease. PLoS One (2012) 0.80
Neurogenesis in Neurotoxin-induced Animal Models for Parkinson's Disease-A Review of the Current Status. J Toxicol Pathol (2009) 0.77
Adult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticity. Neural Plast (2014) 0.77
Viral-toxin interactions and Parkinson's disease: poly I:C priming enhanced the neurodegenerative effects of paraquat. J Neuroinflammation (2012) 0.77
Dopamine Receptor Antagonists Enhance Proliferation and Neurogenesis of Midbrain Lmx1a-expressing Progenitors. Sci Rep (2016) 0.75
Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med (2002) 10.10
Parkinson's disease. First of two parts. N Engl J Med (1998) 5.90
Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron (1999) 5.59
Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A (2002) 5.09
Induction of neurogenesis in the neocortex of adult mice. Nature (2000) 5.04
Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol (1996) 4.54
Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci U S A (2001) 4.36
Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci (1997) 3.61
Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A (2003) 3.52
Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci (2001) 3.23
Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc (2007) 3.00
In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci (1996) 2.72
Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum. Mol Cell Neurosci (2003) 2.68
Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci U S A (2003) 2.36
Neurogenesis and aging: FGF-2 and HB-EGF restore neurogenesis in hippocampus and subventricular zone of aged mice. Aging Cell (2003) 2.27
Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. Proc Natl Acad Sci U S A (2004) 2.20
Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A (2003) 2.12
Intracerebroventricular infusion of insulin-like growth factor-I ameliorates the age-related decline in hippocampal neurogenesis. Neuroscience (2001) 1.94
FGF-2 regulation of neurogenesis in adult hippocampus after brain injury. Proc Natl Acad Sci U S A (2001) 1.90
Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor. J Neurosci (1999) 1.83
The adult substantia nigra contains progenitor cells with neurogenic potential. J Neurosci (2002) 1.78
In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc Natl Acad Sci U S A (2000) 1.67
Stem cell factor stimulates neurogenesis in vitro and in vivo. J Clin Invest (2002) 1.63
FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci U S A (2005) 1.46
doublecortin is the major gene causing X-linked subcortical laminar heterotopia (SCLH). Hum Mol Genet (1998) 1.44
Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. J Neurosci (2002) 1.40
No evidence for new dopaminergic neurons in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A (2004) 1.39
A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res (1995) 1.30
Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration. J Neurosci (2007) 1.21
Differential response of ventral midbrain and striatal progenitor cells to lesions of the nigrostriatal dopaminergic projection. Dev Neurosci (2000) 0.97
Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging. Brain Res (1993) 0.94
Loss of basic fibroblast growth factor in substantia nigra neurons in Parkinson's disease. Neurology (1993) 0.86
Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia (1983) 4.48
Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci U S A (2001) 4.36
Neuroglobin is up-regulated by and protects neurons from hypoxic-ischemic injury. Proc Natl Acad Sci U S A (2001) 3.12
Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A (2000) 3.06
Adequacy of single-locus approximations for linkage analyses of oligogenic traits. Genet Epidemiol (1992) 2.89
Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors. Mol Pharmacol (1977) 2.64
Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol (1991) 2.52
Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am J Hum Genet (2001) 2.51
Magnitude of type I error when single-locus linkage analysis is maximized over models: a simulation study. Am J Hum Genet (1997) 2.38
Ethanol and the nervous system. N Engl J Med (1989) 2.17
Association between a GABRB3 polymorphism and autism. Mol Psychiatry (2002) 2.00
Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci (1998) 1.99
Further evidence for the increased power of LOD scores compared with nonparametric methods. Am J Hum Genet (1999) 1.96
Inter- and intrafamilial heterogeneity: effective sampling strategies and comparison of analysis methods. Am J Hum Genet (1992) 1.91
Affecteds-only linkage methods are not a panacea. Am J Hum Genet (1996) 1.90
Wound signals in plants: A systemic plant wound signal alters plasma membrane integrity. Proc Natl Acad Sci U S A (1984) 1.89
Direct power comparisons between simple LOD scores and NPL scores for linkage analysis in complex diseases. Am J Hum Genet (1999) 1.87
Effect of heterogeneity and assumed mode of inheritance on lod scores. Am J Med Genet (1992) 1.83
Adequacy of single-locus approximations for linkage analyses of oligogenic traits: extension to multigenerational pedigree structures. Hum Hered (1994) 1.69
A molecular-based magnet test for malaria. Am J Clin Pathol (1995) 1.65
Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease. J Neurosci (2001) 1.64
Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain. Science (1978) 1.61
Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci (1999) 1.59
Meat consumption and risk of lung cancer: evidence from observational studies. Ann Oncol (2012) 1.57
Early detection of DNA strand breaks in the brain after transient focal ischemia: implications for the role of DNA damage in apoptosis and neuronal cell death. J Neurochem (1997) 1.57
Evidence for recessive and against dominant inheritance at the HLA-"linked" locus in coeliac disease. Am J Hum Genet (1982) 1.54
Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun (2004) 1.52
Localization of idiopathic generalized epilepsy on chromosome 6p in families of juvenile myoclonic epilepsy patients. Neurology (1991) 1.51
Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal. J Mol Neurosci (2000) 1.50
Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J Neurosci (2000) 1.48
Two locus models for gluten sensitive enteropathy: population genetic considerations. Am J Med Genet (1981) 1.46
Reduction of skeletal muscle necrosis using intermittent hyperbaric oxygen in a model compartment syndrome. J Bone Joint Surg Am (1983) 1.45
Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate. Osteoporos Int (2008) 1.44
The effect of proband designation on segregation analysis. Am J Hum Genet (1986) 1.43
Therapeutically interchangeable? A study of real-world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records data. Diabetes Obes Metab (2014) 1.42
Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience (2001) 1.41
The effects of conditioning on probands to correct for multiple ascertainment. Am J Hum Genet (1984) 1.40
Estimation of the frequency of hexosaminidase a variant alleles in the American Jewish population. Am J Hum Genet (1982) 1.38
Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children. Acta Endocrinol (Copenh) (1983) 1.37
Simulation studies of segregation analysis: application to two-locus models. Am J Hum Genet (1984) 1.36
A simple method for testing two-locus models of inheritance. Am J Hum Genet (1981) 1.33
Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J Biol Chem (2000) 1.33
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology (2009) 1.32
CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab (2001) 1.29
Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states. Life Sci (1976) 1.26
Induction of vascular endothelial growth factor and hypoxia-inducible factor-1alpha by global ischemia in rat brain. Neuroscience (2000) 1.26
Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain. Neuropharmacology (1977) 1.22
Linkage analysis of two-locus diseases under single-locus and two-locus analysis models. Cytogenet Cell Genet (1992) 1.21
Comparative efficacy of expression of genes delivered to mouse sensory neurons with herpes virus vectors. J Comp Neurol (1994) 1.21
Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat. Neurosci Lett (1998) 1.20
Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab (1999) 1.20
A maximum likelihood test of the two locus model for coeliac disease. Am J Med Genet (1982) 1.19
Genome scan of idiopathic generalized epilepsy: evidence for major susceptibility gene and modifying genes influencing the seizure type. Ann Neurol (2001) 1.18
Chinese medicinal herbs for the common cold. Cochrane Database Syst Rev (2007) 1.16
Use of green fluorescent protein (GFP) to study the invasion pathways of Edwardsiella tarda in in vivo and in vitro fish models. Microbiology (2000) 1.16
Global ischemia induces expression of acid-sensing ion channel 2a in rat brain. J Cereb Blood Flow Metab (2001) 1.15
Cyclic GMP modulators and excitotoxic injury in cerebral cortical cultures. Brain Res (1992) 1.15
Induction of vascular endothelial growth factor receptors and phosphatidylinositol 3'-kinase/Akt signaling by global cerebral ischemia in the rat. Neuroscience (2000) 1.12
Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. Am J Med Genet (1996) 1.12
Import of amber and ochre suppressor tRNAs into mammalian cells: a general approach to site-specific insertion of amino acid analogues into proteins. Proc Natl Acad Sci U S A (2001) 1.11
Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X-chromosome. International Consortium for the Genetics of Autoimmune Thyroid Disease. J Clin Endocrinol Metab (1998) 1.11
Variations in virulence between different electrophoretic types of Listeria monocytogenes. Lett Appl Microbiol (2000) 1.10
A chemiluminescence immunoassay for evaluation of Cryptosporidium parvum growth in vitro. FEMS Microbiol Lett (1996) 1.09
Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun (2003) 1.07
Microarray analysis of hippocampal gene expression in global cerebral ischemia. Ann Neurol (2001) 1.06
ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen. Br J Cancer (2008) 1.06
Transcriptome analysis of the central nervous system of the mollusc Lymnaea stagnalis. BMC Genomics (2009) 1.05
Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus. J Clin Endocrinol Metab (2001) 1.05
Assessment of neuronal viability with Alamar blue in cortical and granule cell cultures. J Neurosci Methods (1996) 1.05
The impending Canadian prostate cancer epidemic. Can J Public Health (1996) 1.05
Dynamic axial external fixation in the surgical treatment of tibia vara. J Pediatr Orthop (1995) 1.05
Calcium channels and calcium channel antagonists. Ann Neurol (1987) 1.05
Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson's disease: a dynamic model. Neuroscience (2007) 1.05
Effect of misspecification of gene frequency on the two-point LOD score. Eur J Hum Genet (2001) 1.04
Symptoms in relation to chemicals and dampness in newly built dwellings. Int Arch Occup Environ Health (2004) 1.04
Synthesis of a selenocysteine-containing peptide by native chemical ligation. Org Lett (2001) 1.04
Cyclic AMP response element binding protein (CREB) and CREB binding protein (CBP) in global cerebral ischemia. J Mol Neurosci (2001) 1.03
CB1 cannabinoid receptor induction in experimental stroke. Ann Neurol (2000) 1.03
A new Graves disease-susceptibility locus maps to chromosome 20q11.2. International Consortium for the Genetics of Autoimmune Thyroid Disease. Am J Hum Genet (1998) 1.03
Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia. J Cereb Blood Flow Metab (1997) 1.02
Adeno-associated virus-mediated delivery of BCL-w gene improves outcome after transient focal cerebral ischemia. Gene Ther (2003) 1.01
Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid (2000) 1.01
Identification and characterization of receptor for mammalian hepatopoietin that is homologous to yeast ERV1. J Biol Chem (1999) 1.01
cDNA microarray analysis of changes in gene expression induced by neuronal hypoxia in vitro. Neurochem Res (2002) 1.00
Second-order approximations of ascertainment probabilities. Biometrics (1980) 1.00
Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci Lett (2000) 1.00
PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am J Transplant (2009) 1.00
Sibling recurrence risk in autoimmune thyroid disease. Thyroid (2003) 1.00
XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic Dis (2011) 1.00
Voxel-based morphometric MRI post-processing in MRI-negative focal cortical dysplasia followed by simultaneously recorded MEG and stereo-EEG. Epilepsy Res (2012) 0.99
The heterogeneity problem. I: Separating genetic from environmental forms of the same disease. Am J Med Genet (1985) 0.99
In vitro anticryptosporidial activity of dinitroaniline herbicides. FEMS Microbiol Lett (1996) 0.99
The search for heterogeneity in insulin-dependent diabetes mellitus: evidence for familial and nonfamilial forms. Am J Med Genet (1983) 0.98
alpha-Noradrenergic receptors in the brain: differential effects of sodium on binding of [3H]agonists and [3H]antagonists. Brain Res (1978) 0.98
Anti-AIDS agents--XXVI. Structure-activity correlations of gomisin-G-related anti-HIV lignans from Kadsura interior and of related synthetic analogues. Bioorg Med Chem (1997) 0.98
Long-term outcome of combined penetrating keratoplasty and vitreoretinal surgery using temporary keratoprosthesis. Eye (Lond) (2006) 0.98